Prostate cancer is the process in which cells begin to grow abnormally and crowd out healthy cells. As the abnormal cells multiply, they form a malignant (cancerous) growth or tumor. Prostate cancer is the most common cancer in men after skin cancer. More than 190,000 men in the U.S. will be diagnosed with prostate cancer every year. However, only a small percentage will die from the disease.
Thanks to better screening methods and greater awareness, prostate cancer is being detected much earlier. That is giving men more options for treatment and leading to better survival rates and an improved quality of life. The American Cancer Society estimates that some 2 million men who have been diagnosed with prostate cancer are leading active lives today.
At USMD Prostate Cancer Center, new advancements in prostate testing and biopsies are being used to pinpoint the type, stage and location of prostate cancers with outstanding accuracy. New 3D ultrasonic prostate biopsy technologies are employed to deliver this accuracy and offer a new convenient option for patients who undergo the biopsy procedure.
Not all growths in the prostate are cancerous; some can be benign or non-cancerous. A non-cancerous growth is called benign prostatic hyperplasia (BPH) disease. BPH is a very common condition in men over age 50. It requires treatment,
but it is not malignant.